Comparison between angiography or intravascular imaging guided coronary rotational atherectomy
4 affiliations
- 1Department of Cardiology, The First People’s Hospital of Taicang, No. 58 Changsheng South Road, Chengxiang Town, Taicang City, Jiangsu Province 215400 China
- 2Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, No. 68 Changle Road, Nanjing, Jiangsu Province 210006 China
- 3Department of Cardiology, Huainan Xinhua Medical Group Xinhua Hospital, Huainan, Anhui Province China
- 4Department of Cardiology, Zhangjiagang Hospital Affiliated to Soochow University, The First People’s Hospital of Zhangjiagang City, Zhangjiagang, Jiangsu Province China
Abstract
Background: Rotational atherectomy (RA) is a cornerstone technique for the management of severely calcified coronary lesions during percutaneous coronary interventions. Although intravascular imaging (IVI) provides superior anatomical guidance, its long-term prognostic impact in RA remains underexplored.
Objectives: This study aimed to compare 12-month clinical outcomes between IVI-guided and coronary angiography (CAG)-guided RA.
Methods: This retrospective analysis included 468 patients who underwent RA. Following 1:1 propensity score matching(PSM), 306 patients (153 per group) were compared: IVI-guided versus angiography (CAG)-guided RA. The primary endpoint was 12-month major adverse cardiac events (MACE). A stratified Cox proportional hazards model, incorporating variables selected via least absolute shrinkage and selection operator (LASSO) regression, was employed for the primary adjusted analysis to mitigate overfitting.
Results: Compared with CAG guidance, IVI-guided RA was associated with the use of larger burrs and stent diameters, as well as greater contrast volume (all P<0.05). At 12 months, IVI-guided RA was associated with significantly lower rates of MACE (7.2% vs. 15.0%; P = 0.033), cardiac death (2.0% vs. 8.5%; P = 0.020), and all-cause mortality (2.6% vs. 11.8%; P<0.005). In the stratified multivariable Cox model adjusting for preoperative renal function, IVI guidance remained independently associated with a lower hazard of MACE (adjusted hazard ratio [HR] 0.42, 95% confidence interval [CI] 0.20–0.86; P = 0.018).
Conclusions: In this observational study, IVI-guided RA was associated with reduced 12-month MACE and all-cause mortality compared to CAG-guided RA. These findings generate hypotheses regarding the potential role of IVI guidance in this high-risk setting and underscore the need for validation in prospective, randomised trials.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12872-026-06411-6.
Related
- Intravascular lithotripsy in comparison to rotational atherectomy for calcified lesions: the ICARE OFDI randomised trial
- Intravascular lithotripsy vs. rotational atherectomy for severely calcified coronary lesions with concomitant tortuosity or angulation: a propensity-weighted real-world study from China
- Successful excimer laser coronary atherectomy after failed rotational atherectomy in a balloon-uncrossable chronic total occlusion of the left anterior descending artery
- Stent-less percutaneous coronary intervention for a severely calcified coronary lesion using combined orbital atherectomy and intravascular lithotripsy followed by drug-coated balloon: case report
- Virtual Assessment of Coronary Microcirculation Before and After Rotational Atherectomy
BibTeX
@article{liu2026comparison,
title = {{Comparison between angiography or intravascular imaging guided coronary rotational atherectomy}},
author = {Yichen Liu and Xiaofei Gao and Jingyu Zhao and Ling Lin and Zhicheng Li and Jiaxian Song and Shouming Zhao and Xiangquan Kong},
journal = {BMC Cardiovascular Disorders},
year = {2026},
month = aug,
doi = {10.1186/s12872-026-06411-6},
url = {https://doi.org/10.1186/s12872-026-06411-6},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Comparison between angiography or intravascular imaging guided coronary rotational atherectomy
AU - Yichen Liu
AU - Xiaofei Gao
AU - Jingyu Zhao
AU - Ling Lin
AU - Zhicheng Li
AU - Jiaxian Song
AU - Shouming Zhao
AU - Xiangquan Kong
PY - 2026
DA - 2026/08/11
JO - BMC Cardiovascular Disorders
DO - 10.1186/s12872-026-06411-6
UR - https://doi.org/10.1186/s12872-026-06411-6
AB - Background: Rotational atherectomy (RA) is a cornerstone technique for the management of severely calcified coronary lesions during percutaneous coronary interventions. Although intravascular imaging (IVI) provides superior anatomical guidance, its long-term prognostic impact in RA remains underexplored. Objectives: This study aimed to compare 12-month clinical outcomes between IVI-guided and coronary angiography (CAG)-guided RA. Methods: This retrospective analysis included 468 patients who underwent RA. Following 1:1 propensity score matching(PSM), 306 patients (153 per group) were compared: IVI-guided versus angiography (CAG)-guided RA. The primary endpoint was 12-month major adverse cardiac events (MACE). A stratified Cox proportional hazards model, incorporating variables selected via least absolute shrinkage and selection operator (LASSO) regression, was employed for the primary adjusted analysis to mitigate overfitting. Results: Compared with CAG guidance, IVI-guided RA was associated with the use of larger burrs and stent diameters, as well as greater contrast volume (all P<0.05). At 12 months, IVI-guided RA was associated with significantly lower rates of MACE (7.2% vs. 15.0%; P = 0.033), cardiac death (2.0% vs. 8.5%; P = 0.020), and all-cause mortality (2.6% vs. 11.8%; P<0.005). In the stratified multivariable Cox model adjusting for preoperative renal function, IVI guidance remained independently associated with a lower hazard of MACE (adjusted hazard ratio [HR] 0.42, 95% confidence interval [CI] 0.20–0.86; P = 0.018). Conclusions: In this observational study, IVI-guided RA was associated with reduced 12-month MACE and all-cause mortality compared to CAG-guided RA. These findings generate hypotheses regarding the potential role of IVI guidance in this high-risk setting and underscore the need for validation in prospective, randomised trials. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12872-026-06411-6.
SN - 1471-2261
ER -